ArticleBMJ open2021

Study protocol for SKIPMDD: subcutaneous ketamine infusion in palliative care patients with advanced life limiting illnesses for major depressive disorder (phase II pilot feasibility study).

Wei Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.